ELECSYS PROBNP II
Received Feb 14, 2023 · Event occurred Jan 30, 2023
Report 1823260-2023-00466 · MDR key 16375795
Device
Generic name
Natriuretic Peptide Test
Manufacturer
Roche Diagnostics GmbhModel number
NACatalog number
09315284190
Lot number
630011
Product problems
- Low Test Results
- Non Reproducible Results
- Low Test Results
- Non Reproducible Results
Patient
Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Description of Event or Problem
THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH THE ELECSYS PROBNP II IMMUNOASSAY VER. 2.1 ON A COBAS E 801 ANALYTICAL UNIT (SERIAL NUMBER(B)(4). THE SAMPLE INITIALLY RESULTED IN A PROBNP VALUE OF 18.3 PG/ML AND THIS VALUE WAS REPORTED OUTSIDE OF THE LABORATORY TO MEDICAL PERSONNEL. THE RESULT WAS QUESTIONED SINCE IT DID NOT AGREE WITH THE PATIENT'S CLINICAL PICTURE. THE SAMPLE WAS REPEATED, RESULTING IN A VALUE OF 5299 PG/ML, WHICH WAS DEEMED CORRECT AND MATCHED THE PATIENT'S CLINICAL PICTURE. A SECOND SAMPLE COLLECTED FROM THE PATIENT RESULTED IN A PROBNP VALUE OF > 5000 PG/ML.
Additional Manufacturer Narrative
FACILITY NAME WAS PROVIDED AS "BARRUALDE-GALDAKAOKO ERAKUNDE SANITARIO INTEGRATUA ORGANIZACION SANITARIA INTEGRADA BARRUALDE-GALDAKAO"
Additional Manufacturer Narrative
THE LAST CALIBRATION WAS PERFORMED ON (B)(6) 2022 AND CALIBRATION SIGNALS WERE WITHIN EXPECTATIONS. PER PRODUCT LABELING, RENEWED CALIBRATION IS RECOMMENDED AFTER 12 WEEKS WHEN USING THE SAME REAGENT LOT. CONTROLS WERE WITHIN SPECIFIED RANGES ON THE DAY OF THE EVENT. CALIBRATION AND CONTROLS DO NOT POINT TO A GENERAL REAGENT OR INSTRUMENT PROBLEM. THE SAMPLE CLOTTING TIME WAS SHORTER THAN RECOMMENDED BY THE TUBE MANUFACTURER. UPON REVIEW OF THE ALARM TRACE, AN ABNORMAL SAMPLE ASPIRATION ALARM OCCURRED ON THE DAY OF THE EVENT. ON ANALYSIS OF IMAGES FROM THE SAMPLE FOAM DETECTION CAMERA, A RED BLOOD CELL STRAND WAS VISIBLE WHEN THE TUBE WAS FIRST MEASURED. A FILM WAS ALSO OBSERVED ON THE SURFACE OF THE SAMPLE. THE INVESTIGATION COULD NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. THE ISSUE IS CONSISTENT WITH INCORRECT PRE-ANALYTIC SAMPLE HANDLING.